Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KIF11 | P52732 | 1/20 | 0.45 |
| ▸ | MAOB | P27338 | 4/20 | 0.42 |
| ▸ | MAOA | P21397 | 2/20 | 0.42 |
| ▸ | GABRA1 | P14867 | 3/20 | 0.40 |
| ▸ | GABRB3 | P28472 | 2/20 | 0.40 |
| ▸ | GABRG2 | P18507 | 1/20 | 0.40 |
| ▸ | GABRB2 | P47870 | 2/20 | 0.37 |
| ▸ | ACHE | P22303 | 2/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.35 |
| ▸ | SIRT2 | Q8IXJ6 | 1/20 | 0.33 |
| ▸ | CA1 | P00915 | 1/20 | 0.32 |
| ▸ | CA2 | P00918 | 1/20 | 0.32 |
| ▸ | CA5A | P35218 | 1/20 | 0.32 |
| ▸ | CA9 | Q16790 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30810730 | 0.94 | KIF11 (0.53) | KIF11MAOBMAOAGABRA1GABRB3 | |
| SCHEMBL20336329 | 0.81 | KIF11 (0.61) | KIF11GABRA1GABRB3GABRG2GABRB2 | |
| SCHEMBL15370170 | 0.78 | KIF11 (0.42) | KIF11MAOBMAOAGABRA1GABRB3 | |
| SCHEMBL23860299 | 0.77 | KIF11 (0.45) | KIF11GABRA1GABRB3GABRG2GABRB2 | |
| SCHEMBL20261725 | 0.77 | KIF11 (0.45) | KIF11GABRA1GABRB3GABRG2GABRB2 | |
| SCHEMBL6105719 | 0.77 | KIF11 (0.49) | KIF11GABRA1GABRB3GABRG2GABRB2 | |
| SCHEMBL14655026 | 0.77 | KIF11 (0.49) | KIF11GABRA1GABRB3GABRG2GABRB2 | |
| SCHEMBL4659933 | 0.77 | KIF11 (0.45) | KIF11GABRA1GABRB3GABRG2GABRB2 | |
| SCHEMBL22587365 | 0.77 | KIF11 (0.45) | KIF11MAOBMAOAGABRA1GABRB3 | |
| SCHEMBL18286628 | 0.77 | KIF11 (0.53) | KIF11GABRA1GABRB3GABRG2GABRB2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260055246-A1 | POLYMER FILMS, METHODS FOR PREPARING THEREOF, AND COMPOSITE CURRENT COLLECTORS THEREOF | JIANGYIN NANOPORE INNOVATIVE MATERIALS TECHNOLOGY LTD. (CN) | 2026-02-26 | — | — | US | disclosed |
| US-11913944-B2 | Photoaffinity probes | PROMEGA CORPORATION (US) | 2024-02-27 | — | — | US | disclosed |
| US-11913944-B2 | Photoaffinity probes | PROMEGA CORPORATION (US) | 2024-02-27 | — | — | US | disclosed |
| WO-2024037617-A1 | POLYMER FILMS, METHODS FOR PREPARING THEREOF, AND COMPOSITE CURRENT COLLECTORS THEREOF | JIANGYIN NANOPORE INNOVATIVE MATERIALS TECHNOLOGY LTD (CN) | 2024-02-22 | — | — | WO | disclosed |
| WO-2023225336-A1 | MET BCL-XL INHIBITOR ANTIBODY-DRUG CONJUGATES AND METHODS OF USE THEREOF | NOVARTIS AG (CH) | 2023-11-23 | — | — | WO | disclosed |
| WO-2023215514-A2 | BIOLUMINESCENCE-TRIGGERED PHOTOCATALYTIC LABELING | PROMEGA CORPORATION (US) | 2023-11-09 | — | — | WO | disclosed |
| US-11807623-B2 | Nucleic acid-binding photoprobes and uses thereof | ARRAKIS THERAPEUTICS, INC. (US) | 2023-11-07 | — | — | US | disclosed |
| US-20230312520-A1 | NUCLEIC ACID-BINDING PHOTOPROBES AND USES THEREOF | ARRAKIS THERAPEUTICS, INC. | 2023-10-05 | — | — | US | disclosed |
| US-20230176063-A1 | PHOTOREACTIVE AND CLEAVABLE PROBES FOR TAGGING BIOMOLECULES | ACADEMIA SINICA (TW) | 2023-06-08 | — | — | US | disclosed |
| US-20220317138-A1 | METHODS FOR DETERMINING THE CONCENTRATION OF A CARBAPENEM ANTIBIOTIC IN A BIOLOGICAL SAMPLE | Université de Liège (BE) | 2022-10-06 | — | — | US | disclosed |
| US-20170065726-A1 | NOVEL CROSSLINKING REAGENTS, MACROMOLECULES, THERAPEUTIC BIOCONJUGATES, AND SYNTHETIC METHODS THEREOF | CELLMOSAIC INC (US) | 2017-03-09 | — | — | US | disclosed |
| US-9511150-B2 | Crosslinking reagents, macromolecules, therapeutic bioconjugates, and synthetic methods thereof | CellMosaic, Inc. (US) | 2016-12-06 | — | — | US | disclosed |
| US-8907079-B2 | Crosslinking reagents, macromolecules, therapeutic conjugates, and synthetic methods thereof | CELLMOSAIC INC. (US) | 2014-12-09 | — | — | US | disclosed |
| US-20140206903-A1 | NOVELCROSSLINKING REAGENTS, MACROMOLECULES, THERAPEUTIC CONJUGATES, AND SYNTHETIC METHODS THEREOF | CELLMOSAIC INC (US) | 2014-07-24 | — | — | US | disclosed |
| WO-2012173575-A1 | ALKYLAMINO BODIPY DYES AS SELECTIVE FLUORESCENT PROBES FOR PROTEINS AND MOUSE EMBRYONIC STEM CELLS | NATIONAL UNIVERSITY OF SINGAPORE (SG) | 2012-12-20 | — | — | WO | disclosed |
| EP-2116839-A1 | Device for multiple ATR analysis | Université Catholique de Louvain (BE) | 2009-11-11 | — | — | EP | disclosed |
| US-20090130776-A1 | BINDING PROTEIN MOLECULE | CANON KABUSHIKI KAISHA (JP) | 2009-05-21 | — | — | US | disclosed |
| US-20090130776-A1 | BINDING PROTEIN MOLECULE | CANON KABUSHIKI KAISHA (JP) | 2009-05-21 | — | — | US | disclosed |
| US-20080072794-A1 | Reactive Silicon Suboxide Flakes | HOPPE HOLGER | 2008-03-27 | — | — | US | disclosed |
| US-7176297-B2 | Photoactivatable silane compounds and methods for their synthesis and use | AFFYMETRIX, INC. (US) | 2007-02-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230312520-A1 | NUCLEIC ACID-BINDING PHOTOPROBES AND USES THEREOF | NSUN3, NSUN2, TARBP1 | KIF11 4227/4885MAOB 1343/4885MAOA 2886/4885 |
| US-20260055246-A1 | POLYMER FILMS, METHODS FOR PREPARING THEREOF, AND COMPOSITE CURRENT COLLECTORS THEREOF | TET2, PRPF40A, CFAP410 | KIF11 2046/4885MAOB 1051/4885MAOA 316/4885 |
| US-20170065726-A1 | NOVEL CROSSLINKING REAGENTS, MACROMOLECULES, THERAPEUTIC BIOCONJUGATES, AND SYNTHETIC METHODS THEREOF | CD44, ADH1C, EPCAM | KIF11 370/4885MAOB 4316/4885MAOA 4481/4885 |
| US-20090130776-A1 | BINDING PROTEIN MOLECULE | CD2BP2, HSPBP1, MYBBP1A | KIF11 4287/4885MAOB 3741/4885MAOA 3430/4885 |
| US-11807623-B2 | Nucleic acid-binding photoprobes and uses thereof | NSUN3, NSUN2, TARBP1 | KIF11 4227/4885MAOB 1343/4885MAOA 2886/4885 |
| US-20140206903-A1 | NOVELCROSSLINKING REAGENTS, MACROMOLECULES, THERAPEUTIC CONJUGATES, AND SYNTHETIC METHODS THEREOF | CD44, ADH1C, EPCAM | KIF11 274/4885MAOB 4300/4885MAOA 4589/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.